Avadel Pharmaceuticals – New Data On Narcolepsy Treatment
Jennifer Gudeman, Vice President, Medical and Clinical Affairs at Avadel Pharmaceuticals discusses new clinical data from the pivotal phase 3 REST-ON cl...
5306 articles
Jennifer Gudeman, Vice President, Medical and Clinical Affairs at Avadel Pharmaceuticals discusses new clinical data from the pivotal phase 3 REST-ON cl...
Jeffrey Cleland, Ph.D., Chairman, CEO and President of Ashvattha Therapeutics, a clinical stage biotech company discusses treatments that are in develop...
Adam Levy, CEO of NEXGEL, advanced hydrogel solutions, discusses their unique water-based hydrogels designed differently from all other adhesives, tapes...
Millions of people worldwide are currently impacted by heart valve disease, and one in eight people aged 75 and older have the most common form, aortic ...
Reid Robison, Chief Medical Officer of Novamind discusses psychedelic medicine and Novamind's leading network of psychedelic-assisted psychiatry clinics...
Anthony Rullo, PhD, Assistant Professor of Medicine at McMaster University discusses the Anna Biosciences Syntem Platform that deploys engineered propri...
Brian LaMoreaux, MD, MS, Medical Director, Medical Affairs at Horizon Therapeutics plc discusses data presented at the 2021 European Alliance Of Associa...
The safe adoption of AI can benefit mammography departments as they strive to deliver on the goals of the national breast screening program.
Branko Kolvek, SVP of Operations at Pager, discusses the company’s virtual care collaboration platform while exploring the differences between telehea...
Nancy Di Dia, Executive Director, Chief Diversity & Inclusion Officer & Head, US DICE at Boehringer Ingelheim USA discusses her 15 years as a D&I office...